Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine-augmented exposure therapy in adolescents with obsessive-compulsive disorder
2008-006947-38Phase 4Completed
- Sponsor
- King's College London
- Start
- Jul 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing D-cycloserine + CBT exposure with Placebo + CBT exposure (2 arms). Primary endpoint: Childrens' Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). Started Jul 2009; status: completed.
02
Drugs
d-cycloserine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on 2008-006947-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006947-38.